Bacterial infections are caused by pathogenic bacteria that invade the body, leading to a wide range of illnesses. Bacteria are single-celled microorganisms that can be both beneficial and harmful. Infections can occur in various parts of the body, affecting the respiratory system, gastrointestinal tract, skin, urinary tract, and more. Common bacterial infections include strep throat, urinary tract infections, pneumonia, and bacterial gastroenteritis. Symptoms can vary but often include fever, pain, inflammation, and other signs of localized or systemic illness. Bacterial infections are typically treated with antibiotics, which are medications specifically designed to target and eliminate bacteria. However, overuse or misuse of antibiotics can contribute to antibiotic resistance, a global health concern. Preventive measures for bacterial infections include practicing good hygiene, such as handwashing, proper food handling, and vaccinations. Immunizations against bacterial pathogens have been instrumental in preventing serious bacterial diseases. While many bacterial infections can be effectively treated with antibiotics, some may become chronic or recurrent, requiring ongoing management. Timely diagnosis and appropriate treatment are crucial for addressing bacterial infections and preventing complications.
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States
Title : Capillary electrophoresis for adjuvanted multivalent recombinant vaccine purity determination
Ashley Prout, Merck, United States
Title : Hypersensitivity and anti-SARS-COV-2 vaccination: A retrospective study of the year 2021 at the University Hospital Center of Tours (France)
Faure Quentin, The Savoie Metropolitan Hospital Center, France
Title : THE HPV vaccination program in Colombia. From a beautiful dream to a nightmare, but hopefully with a bright dawn.
Carlos Castro, Colombian League against cancer, Colombia